PROTARA THERAPEUTIC INC (TARA) Stock Income Statement
USA - NASDAQ:TARA - US74365U1079 - Common Stock
3.07 USD
-0.09 (-2.85%)
3.07 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 57.02M | 49.00M | 44.00M | 37.54M | 47.49M | |||
| Research and Development | 37.49M | N/A | 24.79M | 16.67M | 21.09M | |||
| Selling, General, and Administrative Expenses | 19.86M | 17.00M | 18.00M | 20.63M | 26.40M | |||
| Operating Income | -57.02M | -49.00M | -44.00M | -37.54M | -47.49M | |||
| Interest Income/Expense | 5.62M | N/A | 3.19M | 1.11M | 240.00K | |||
| Other Income/Expense | N/A | 4.00M | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | -29.52M | N/A | |||
| Income Before Taxes | -50.64M | -45.00M | -40.00M | -65.95M | -47.25M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -50.64M | -45.00M | -40.00M | -65.95M | -47.25M | |||
| EBITDA | -55.63M | -47.66M | -42.65M | -37.29M | -47.37M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.61 | -2.14 | -3.63 | -5.86 | -4.21 | |||
| Non GAAP EPS | -1.63 | -2.41 | -3.57 | -3.99 | -4.21 | |||
| Statistics | ||||||||
All data in USD